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General practice
Intergenerational 20 year trends in the prevalence of
asthma and hay fever in adults: the Midspan family study
surveys of parents and offspring
Mark N Upton, Alex McConnachie, Charles McSharry, Carole L Hart, George Davey Smith,
Charles R Gillis, Graham C M Watt
Abstract
Objective To estimate trends between 1972›6 and
1996 in the prevalences of asthma and hay fever in
adults.
Design Two epidemiological surveys 20 years
apart. Identical questions were asked about
asthma, hay fever, and respiratory symptoms at each
survey.
Setting Renfrew and Paisley, two towns in the west of
Scotland.
Subjects 1477 married couples aged 45›64
participated in a general population survey in 1972›6;
and 2338 offspring aged 30›59 participated in a 1996
survey. Prevalences were compared in 1708 parents
and 1124 offspring aged 45›54.
Main outcome measures Prevalences of asthma, hay
fever, and respiratory symptoms.
Results In never smokers, age and sex standardised
prevalences of asthma and hay fever were 3.0% and
5.8% respectively in 1972›6, and 8.2% and 19.9% in
1996. In ever smokers, the corresponding values were
1.6% and 5.4% in 1972›6 and 5.3% and 15.5% in
1996. In both generations, the prevalence of asthma
was higher in those who reported hay fever (atopic
asthma). In never smokers, reports of wheeze not
labelled as asthma were about 10 times more
common in 1972›6 than in 1996. With a broader
definition of asthma (asthma and/or wheeze), to
minimise diagnostic bias, the overall prevalence of
asthma changed little. However, diagnostic bias
mainly affected non›atopic asthma. Atopic asthma
increased more than twofold (prevalence ratio 2.52
(95% confidence interval 1.01 to 6.28)) whereas the
prevalence of non›atopic asthma did not change (1.00
(0.53 to 1.90)).
Conclusion The prevalence of asthma in adults has
increased more than twofold in 20 years, largely in
association with trends in atopy, as measured
indirectly by the prevalence of hay fever. No evidence
was found for an increase in diagnostic awareness
being responsible for the trend in atopic asthma, but
increased awareness may account for trends in
non›atopic asthma.
Introduction
The prevalence of asthma has increased in children
during the past few decades.1 2 As childhood asthma
may persist or recur during adulthood, an increasing
prevalence of asthma in adults is expected as cohorts
of children increasingly affected by asthma become
older. Studies of students3 and conscripts4 suggest that
the prevalence of asthma is rising in young adults, but
little information exists at older ages.
Methodological questions often dominate the
interpretation of secular trends.5 To minimise bias, the
same survey instrument should be used on two or
more occasions in populations that are defined as far
as possible in the same way. As there is no test for
asthma, the detection of secular trends relies on ques›
tionnaires. Changes in awareness and diagnosis of
asthma may influence trends detected by question›
naire, so it is important to ask about symptoms. In
older populations, however, cigarette smoking makes it
difficult to attribute symptoms to asthma.6
We compared the prevalence of asthma and hay
fever, and the combined prevalence of recognised and
unrecognised asthma, in two generations of men and
women aged 45 to 54 years. Both generations had
taken part in the Midspan family study in Renfrew and
Paisley, in the west of Scotland; the older generation
had taken part in 1972›67 and the younger generation
(the offspring) in 1996.8
Methods
Sampling
Parents—All residents of Renfrew and Paisley aged 45
to 64 years were invited in 1972›6 to complete a ques›
tionnaire and attend a cardiorespiratory examination;
15 406 men and women participated (response rate
78%),7 among whom there were 4064 married couples.
Offspring—Offspring were identified by writing to
survivors in the couples who had participated. Where
records showed that husband and wife had both died,
permission was obtained from the privacy committee
of the registrar general for Scotland to write to the
death certificate informant.9 Addresses of survivors or
informants were available for 3445 couples, and replies
were received from 2841. We identified 4829 offspring
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aged 30›59 years from up to 2365 couples with
children (the precise number is unknown because 200
couples did not want to take part in the pilot study in
which we traced offspring); 3202 offspring from 1767
families lived locally and formed the eligible popula›
tion. In 1996 these offspring were invited to complete a
questionnaire and attend a cardiorespiratory examina›
tion at a community clinic.8 In all, 1040 male and 1298
female offspring from 1477 families participated
(response rate for individuals was 73% and for families
was 84%). Approval for the study was obtained from
appropriate local research ethics committees.
Survey methods
The following questions, extracted or adapted from the
1965›6 version of the Medical Research Council’s
questionnaire,10 were asked at both surveys:
x Hay fever: “Do you suffer from, or have you ever suf›
fered from, hay fever?”
x Asthma: “Do you suffer from, or have you ever
suffered from, asthma?”
x Wheeze: “Does your chest sound wheezy or
whistling on most days (or nights)?”
x Chronic sputum: “Do you usually bring up any
phlegm from your chest first thing in the morning in
the winter?” and “Do you bring up phlegm like this on
most days for as much as three months in the winter
each year?”
x Breathlessness: “Do you get short of breath walking
with other people of your own age on level ground?”
In 1996, offspring also answered the European
Community respiratory health survey questionnaire.11
There were small differences between the surveys in
smoking questions, chiefly because the 1970s instru›
ment did not ask about occasional smoking. We have
ignored pipe or cigar use, which were and are uncom›
mon. Social class was coded using the registrar gener›
al’s classification.12
Analysis
Statistical procedures were performed in STATA.13
Prevalences were directly standardised for age in five
year age groups. We used logistic regression to adjust
for age when testing the significance (P < 0.05) of
differences between parents and other participants. We
estimated prevalence ratios (95% confidence intervals)
between generations using logistic regression, adjust›
ing for age, sex, and other covariates as indicated, and
for familial clustering. Any effect of clustering will be
small because the mean number of offspring (aged
45›54) per family was 1.3.
Results
The ages of parents and offspring mainly overlapped
at 45›54. In 1972›6, 7897 participants aged 45›54 had
complete data, of whom 1708 were parents of offspring
who participated in 1996. Of 2338 participant
offspring, 1124 were aged 45›54 with complete data. At
ages 45›49 and 50›54 there were respectively 213 and
524 fathers, 443 and 528 mothers, 322 and 172 sons,
405 and 225 daughters. The total number of
participants was therefore 2832.
Selection of parents
The prevalences of hay fever, asthma, wheeze, chronic
sputum, and breathlessness were lower in the family
study parents compared with those of other partici›
pants in 1972›6, but only the difference for wheeze in
women was significant (table 1). Differences in the
prevalence of symptoms between parents and other
participants participating in 1972›6 were largely
explained by differences in smoking and social class
(data not shown).
Changes in prevalence of respiratory illness,
smoking, and social class
Table 2 shows the changes in the prevalences of respi›
ratory illness, smoking, and social class during the 20
year interval. The prevalences of hay fever and asthma
increased: for hay fever, from 5.4% and 5.8% in men
and women respectively in 1972›6 to 15.4% and 20.0%
in 1996; for asthma, from 1.4% and 2.8% in 1972›6 to
4.9% and 8.0% in 1996. In both generations the preva›
lence of asthma was higher in participants with hay
fever. Despite the increased prevalence of asthma in
the 1996 survey, the prevalence of wheeze had
decreased in men and women, as had the prevalences
of chronic sputum and breathlessness. The prevalence
of current smoking halved in men and women between
Table 1 Age standardised prevalences (numbers of participants) of respiratory illness in
Renfrew and Paisley study during 1972›6 in parents aged 45›54 whose offspring
subsequently participated during 1996, and in all other participants aged 45›54 in
1972›6 study
Men Women
Family study
fathers (n=737)
All other
participants
(n=2994)
Family study
mothers (n=971)
All other participants
(n=3195)
Hay fever 5.4 (42) 6.0 (181) 5.8 (56) 7.6 (243)
Asthma 1.4 (13) 2.7 (82) 2.8 (27) 3.3 (105)
Wheeze 13.9 (109) 15.6 (465) 9.0 (88) 11.8 (377)*
Chronic sputum 23.9 (181) 26.3 (787) 13.4 (130) 13.9 (445)
Breathlessness 9.0 (67) 10.5 (308) 13.2 (128) 15.6 (497)
Standardisation for age differences means that percentages differ from estimates based on raw numerators
and denominators.
*P<0.05 for family study mothers versus all other female participants.
Table 2 Age standardised prevalences (numbers of participants) of respiratory illness,
smoking, and social class at age 45›54 years
Men Women
Fathers, 1972›6
(n=737)
Sons, 1996
(n=494)
Mothers, 1972›6
(n=971)
Daughters, 1996
(n=630)
Respiratory illness
Hay fever 5.4 (42) 15.4 (79) 5.8 (56) 20.0 (128)
Asthma:
In those without hay
fever
1.0 (9)* 4.1 (16)* 1.8 (16)* 4.8 (25)*
In those with hay fever 9.7 (4)† 9.1 (9)† 19.9 (11)† 20.5 (26)†
All 1.4 (13) 4.9 (25) 2.8 (27) 8.0 (51)
Wheeze 13.9 (109) 5.7 (28) 9.0 (88) 4.7 (27)
Chronic sputum 23.9 (181) 14.2 (73) 13.4 (130) 7.0 (43)
Breathlessness 9.0 (67) 6.3 (29) 13.2 (128) 9.2 (60)
Cigarette smoking
Never 20.4 (151) 38.2 (199) 40.0 (389) 46.2 (296)
Former 24.6 (190) 35.4 (166) 8.3 (81) 29.4 (185)
Current 55.0 (396) 26.4 (129) 51.7 (501) 24.4 (149)
Social class
Non›manual 32.5 (242) 55.4 (274) 47.2 (457) 76.7 (480)
Manual 67.5 (495) 44.6 (220) 52.8 (514) 23.3 (150)
Standardisation for age differences means that percentages differ from estimates based on raw numerators
and denominators.
*Denominator is those without hayfever.
†Denominator is those with hayfever.
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1972›6 and 1996. The proportion of men and women
who were manual workers also fell.
“Ever asthma,” current asthma, and wheeze
Of the participants with asthma, 40% (16/40) and 16%
(12/76) reported wheeze most days in 1972›6 and
1996 respectively. Participants in 1972›6 were not
asked about medication. Improvements between
surveys in the treatment of asthma, however, may
explain the reduction in the prevalence of wheeze in
those who reported asthma: 47% (36/76) of asthmatic
participants reported using inhaled corticosteroids in
1996. Although wheeze was the symptom most
strongly associated with asthma, the observation at
both surveys that fewer than half of the asthmatic par›
ticipants reported wheeze probably also reflects the
severity of the definition of wheeze (most days) and the
use of “ever” rather than “current” asthma. In 1996,
62% (47/76) of participants with ever asthma had cur›
rent asthma according to the criteria of the European
Community respiratory health survey—that is, they
were receiving medication for asthma or had
experienced an attack of asthma in the previous 12
months, or both of these. Of these 47 participants,
23%11 reported wheeze most days and 81%38 reported
wheeze at some time during the previous year.
Prevalence changes stratified by smoking
Table 3 shows the changes in prevalence of respiratory
illness by smoking status. The prevalences of asthma
and hay fever increased between surveys irrespective of
smoking: fully adjusted prevalence ratios for hay fever
were 3.53 (95% confidence interval 2.30 to 5.43) and
2.76 (1.91 to 3.98) in never and ever smokers
respectively, and those for asthma were 2.60 (1.41 to
4.80) and 2.69 (1.49 to 4.84). In never smokers the
prevalence of wheeze was lower in 1996 than in 1972›6
(0.32 (0.11 to 0.90)), whereas the prevalences of
chronic sputum and breathlessness were unchanged.
In ever smokers the prevalence of symptoms changed
little between surveys. In combined data for never and
ever smokers, including adjustments for smoking
status and pack years, the fully adjusted prevalence
ratio for wheeze was 0.68 (0.48 to 0.99).
Diagnostic bias
Ten times as many never smokers reported wheeze but
not asthma in 1972›6 (3.4%17) compared with 1996
(0.3%2). This finding is based on small numbers, but a
similar age standardised proportion of never smokers
reported wheeze but not asthma in the entire 1972›6
survey (3.5% (74/2345)). In 1996, none of the never
smokers who denied asthma or wheeze reported using
inhaled corticosteroids, so the low prevalence of
wheeze that was not labelled as asthma was unlikely to
be due to treatment. To minimise diagnostic bias we
combined participants with asthma with those who
reported wheeze (whether or not they reported
asthma) as a new group (asthma and/or wheeze).
Whereas the prevalence of reported asthma increased
more than twofold between surveys, the prevalence of
reported asthma and/or wheeze in never smokers
changed little (fully adjusted prevalence ratio 1.40
(0.83 to 2.36)).
Hay fever and asthma
Clinicians and epidemiologists often use hay fever as a
marker of atopy. Table 3 shows the prevalence of
asthma in participants with and without hay fever, esti›
mated by using individuals in each stratum as denomi›
nator. Asthma increased between the surveys in those
without but not with hay fever (heterogeneity test
P = 0.02). Even though asthma was no more frequent
at the later survey in those with hay fever, the increased
prevalence of hay fever in the whole population
resulted in an increased proportion of the population
who reported both asthma and hay fever (atopic
asthma). We estimated prevalence trends for atopic
and non›atopic asthma in never smokers. Using the
narrow definition of asthma, table 4 shows an
increased prevalence of atopic and non›atopic asthma
between 1972›6 and 1996. However, using the broad
definition (asthma and/or wheeze) only atopic asthma
increased between surveys. Diagnostic bias therefore
mainly affected non›atopic asthma. Findings were
unchanged when we restricted the analysis to parents
Table 3 Age and sex standardised prevalences (numbers of participants) of respiratory
illness by smoking status, and prevalence ratios in 1996 compared with 1972›6 in men
and women aged 45›54 years
1972›6 1996
Prevalence ratio
adjusted for age
and sex
Prevalence ratio
adjusted for all
covariates*
Never smokers n=540 n=495
Hay fever 5.8 (34) 19.9 (110) 4.17 (2.75 to 6.32) 3.53 (2.30 to 5.43)
Asthma:
In those without hay fever 1.8 (12)† 6.3 (23)† 2.54 (1.21 to 5.33) 2.86 (1.36 to 6.02)
In those with hay fever 18.1 (8)‡ 13.0 (19)‡ 0.65 (0.24 to 1.77) 0.76 (0.25 to 2.36)
All 3.0 (20) 8.2 (42) 2.38 (1.34 to 4.23) 2.60 (1.41 to 4.80)
Wheeze 4.6 (24) 1.1 (6) 0.31 (0.12 to 0.80) 0.32 (0.11 to 0.90)
Chronic sputum 5.1 (26) 5.1 (28) 1.03 (0.60 to 1.79) 1.11 (0.60 to 2.04)
Breathlessness 8.3 (55) 6.3 (32) 0.68 (0.42 to 1.09) 0.92 (0.55 to 1.53)
Asthma and/or wheeze 6.4 (37) 8.5 (44) 1.33 (0.83 to 2.15) 1.40 (0.83 to 2.36)
Ever smokers n=1168 n=629
Hay fever 5.4 (64) 15.5 (97) 3.21 (2.28 to 4.53) 2.76 (1.91 to 3.98)
Asthma:
In those without hay fever 1.0 (13)† 3.4 (18)† 3.17 (1.57 to 6.42) 2.92 (1.37 to 6.23)
In those with hay fever 11.6 (7)‡ 15.9 (16)‡ 1.46 (0.54 to 3.95) 0.95 (0.33 to 2.76)
All 1.6 (20) 5.3 (34) 3.36 (1.94 to 5.82) 2.69 (1.49 to 4.84)
Wheeze 14.2 (173) 8.1 (49) 0.53 (0.37 to 0.76) 0.79 (0.53 to 1.17)
Chronic sputum 23.9 (285) 14.2 (88) 0.50 (0.38 to 0.66) 0.73 (0.55 to 0.97)
Breathlessness 12.0 (140) 8.8 (57) 0.75 (0.54 to 1.05) 0.85 (0.59 to 1.22)
Asthma and/or wheeze 15.1 (184) 12.0 (75) 0.77 (0.57 to 1.04) 1.04 (0.76 to 1.43)
Standardisation for age differences means that percentages differ from estimates based on raw numerators
and denominators.
*Age, sex, and social class in never smokers; and age, sex, social class, pack years, and former or current
status in ever smokers.
†Denominator is those without hay fever.
‡Denominator is those with hay fever.
Table 4 Age and sex standardised prevalences (numbers of participants) of asthma
(“asthma” and “asthma and/or wheeze”) in never smokers by hay fever status, and
prevalence ratios in 1996 compared with 1972›6
Asthma definition 1972›6 (n=540) 1996 (n=495)
Prevalence ratio adjusted
for all covariates P value
Asthma:
With hay fever 1.3 (8) 3.0 (19) 2.65 (0.99 to 7.09) 0.052
Without hay fever 1.7 (12) 5.2 (23) 2.43 (1.13 to 5.19) 0.023
All 3.0 (20) 8.2 (42) 2.60 (1.41 to 4.80) 0.002
Asthma and/or wheeze:
With hay fever 1.4 (9) 3.2 (20) 2.52 (1.01 to 6.28) 0.048
Without hay fever 5.0 (28) 5.3 (24) 1.00 (0.53 to 1.90) 0.996
All 6.4 (37) 8.5 (44) 1.40 (0.83 to 2.36) 0.203
Standardisation for age differences means that percentages differ from estimates based on raw numerators
and denominators.
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and married offspring or substituted all participants of
the 1972›6 survey for the parents (data not shown).
Discussion
Methodology
Parents participated in a general population survey
with a high response.7 Families in which two
generations participated were not randomly drawn
from all families in Renfrew and Paisley because the
combination of a successful response to offspring trac›
ing9 in 1993›4 and offspring participation8 in 1996 ret›
rospectively ‘‘selected” couples who were healthier than
the general population. Absolute prevalences of respi›
ratory illness in parents slightly underestimate those in
the general population survey, but it is reasonable to
expect intergenerational trends in these families to fol›
low trends in the general population. It is likely that we
underestimated the lifetime prevalence of asthma and
hay fever because recall tends to reflect prevalence over
a shorter time period.14 We asked identical questions
about respiratory illness at both surveys but did not
measure bronchial responsiveness or atopy.
Main findings
We found a twofold to threefold increase between
1972›6 and 1996 in the prevalences of lifetime asthma
and hay fever reported by adults aged 45›54, irrespec›
tive of smoking. In never smokers, reports of wheeze
not labelled as asthma were about 10 times more com›
mon in parents and all participants of the general
population survey in 1972›6 compared with offspring
in 1996. In view of the increased professional and pub›
lic awareness of asthma since the 1980s,15 our findings
probably reflect underrecognition of asthma 20 years
ago. To assess the effect of possible diagnostic bias, and
also confounding by cigarette smoking, we reviewed
trends in the prevalence of any report of asthma
and/or wheeze in never smokers. Little difference
existed between parents and offspring in the
prevalence of this broader definition of asthma.
Subgroup analysis showed that the increased clinical
recognition of asthma had occurred in non›atopic
rather than atopic participants (using the presence of
hay fever as a marker of atopy). Based on our broader
definition of asthma, the prevalence of non›atopic
asthma did not change between 1972›6 and 1996, but
the prevalence of atopic asthma increased more than
twofold.
Comparison with other studies
Few opportunities exist for comparing prevalences of
asthma and hay fever at an interval of 20 years in older
adults because most epidemiological studies during
the 1970s focused on cardiovascular disease and
chronic bronchitis. To our knowledge this is the first
population study of secular trends of respiratory illness
in older adults that is stratified by smoking. Fleming
and Crombie16 reported twofold rises in consultation
rates for asthma and hay fever in British general prac›
tices at all ages between 1970›1 and 1980›1, but lack of
information about smoking and symptoms may have
biased this study16 and other studies based solely on
healthcare records. In repeated Australian surveys,17
hay fever increased between 1981 and 1990, but the
prevalences of wheeze and diagnosed asthma
increased only in those aged below 40. Reviewing Brit›
ish population studies, Cook et al6 reported that the
prevalence of chronic sputum, but not wheeze, had
fallen in line with decreased smoking and suggested
that wheeze may have been sustained by factors related
to asthma that were increasing. In our study, reports of
wheeze most days decreased over time (despite
increased asthma) and fewer asthmatics reported
wheeze in 1996 than in 1972›6. This may be the result
of improved asthma treatment. Although we did not
record medication in 1972›6, primary care cortico›
steroid prescriptions for asthma increased more than
sixfold between 1980 and 1990.18
Heterogeneity of asthma
Without objective measurements we cannot be certain
that the prevalence of atopy increased between
surveys, nor can we validate the atopic status of the
groups with and without hay fever. Strong positive
associations between hay fever and asthma at both sur›
veys support the validity of hay fever as an atopic
marker, but relations between asthma, hay fever, skin
test reactivity, and immunoglobulin E are complex.19 20
The heterogeneity of asthma in children is well recog›
nised, but in studies of respiratory disease in adults
asthma is often considered as a single entity to be dis›
tinguished from emphysema and chronic obstructive
pulmonary disease.20 21 Studies that have used atopic
markers to subdivide asthma in adults have shown dif›
ferences in rate of decline of lung function22 and mor›
tality.23 It is therefore important to investigate which
asthma phenotypes are becoming more common. Our
results are consistent with reported increases in preva›
lence of atopic, rather than non›atopic, wheeze in chil›
dren.24
Conclusion
The prevalence of asthma in adults has increased more
than twofold in 20 years, largely in association with
trends in atopy, as measured indirectly by the
prevalence of hay fever. Greater diagnostic awareness
does not seem to be responsible for the trend in atopic
What is already known on this topic
The prevalences of asthma and atopy have
increased in children, university students, and
conscripts during the past few decades, but little
information exists about trends at older ages
Prevalence trends detected by questionnaire are
vulnerable to biases, including information bias
from changed awareness and diagnosis of asthma
What this study adds
The prevalence of asthma in adults has increased
more than twofold in 20 years, largely in
association with trends in atopy (indexed by hay
fever)
No evidence was found for increased diagnostic
awareness being responsible for the trend in
atopic asthma, but increased awareness may
account for trends in non›atopic asthma
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asthma, but increased awareness may account for
trends in non›atopic asthma.
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Memorable patients
Up close and personal
I recently had the opportunity to observe the progress of two
middle aged women admitted to hospital after a stroke. I
occupied the bed between them. Both had similar levels of
impairment and had been in hospital for several months, and
plans for their discharge were progressing.
Mary could easily have graced the “memorable patient”
column. She was intelligent, articulate, despite severe dysarthria,
was positive, willing to give anything a go, and had a wicked,
infectious sense of humour. She was popular. Ruth on the other
hand was quiet, and somewhat introverted, complained a lot, and
found every step in her rehabilitation fraught with danger.
Around Mary’s bed there was always a throng of visitors, and
when they left it was difficult to see her for the flowers and
garlands of cards. In contrast, Ruth rarely had visitors and had
only a handful of cards. She told me that she preferred to sleep
through visiting times to dispel her loneliness. Very occasionally
she became animated and chatty, such as on return from a car
trip with people from the local church.
It is generally accepted that personality and social support are
the best predictors of recovery, and it will come as no surprise
that Mary’s functional progress was excellent and Ruth’s was slow.
What came as a surprise to me was not the contrast between the
two women but the contrast in the way that they were treated. I
saw the effects of throw away comments made by the staff, half
joking, half serious, that built up the one and diminished the
other. I watched the subtle differences in approach that could
have unintentional but devastating effects.
Mary’s small steps of progress were greeted with delighted cries
of “Well done, you’re a star. Keep up the good work.” Ruth’s
faltering steps usually provoked such responses as, “See. We told
you you could do it. What was there to be so frightened of after
all?” It was as if people believed that Ruth’s fear of falling could be
reasoned or even bullied away. I do not know how many of the
staff had been able to sit with her long enough to learn that when
she had her stroke she fell backwards down a flight of stairs. She
remembers hitting every single step. Ruth complained of being
ignored, and it was not paranoia. She gave little back to those who
did try to help her. She did not have the energy.
It seemed as if Mary, who had everything, was given more, and
Ruth, who had so little, had even that taken away. Have I been
guilty of doing that? We can and should learn from our
exceptional patients, but our understanding, compassion, and
skills should extend to all our patients. I am starting to improve
by acknowledging that my actions and casual comments can so
easily and subtly undermine this ideal.
General practice
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